A Chinese version of the psychotic symptom rating scales : psychometric properties in recent-onset and chronic psychosis by Chien, WT et al.
© 2017 Chien et al. This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php 
and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you 
hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission 
for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
Neuropsychiatric Disease and Treatment 2017:13 745–753
Neuropsychiatric Disease and Treatment Dovepress
submit your manuscript | www.dovepress.com
Dovepress 
745
O r i g i N a l  r e s e a r c h
open access to scientific and medical research
Open access Full Text article
http://dx.doi.org/10.2147/NDT.S131174
a chinese version of the Psychotic symptom 
rating scales: psychometric properties in 
recent-onset and chronic psychosis
Wai-Tong chien1
isabella Yuet-Ming lee2
li-Qun Wang3
1school of Nursing, Faculty of 
health and social sciences, The 
hong Kong Polytechnic University, 
hung hom, Kowloon, hong Kong, 
People’s republic of china; 2central 
Nursing Division, ruttonjee Tang 
shiu King hospital, Wan chai, hong 
Kong, People’s republic of china; 
3school of Nursing, Jilin Medical 
college, Jilin city, Jilin Province, 
People’s republic of china
Abstract: The purpose of this study was to test the reliability, validity, and factor structure of 
a Chinese version of the Psychotic Symptom Rating Scale (PSYRATS) in 198 and 202 adult 
patients with recent-onset and chronic psychosis, respectively. The PSYRATS has been translated 
into different language versions and has been validated for clinical and research use mainly in 
chronic psychotic patients but not in recent-onset psychosis patients or in Chinese populations. 
The psychometric analysis of the translated Chinese version included assessment of its content 
validity, semantic equivalence, interrater and test–retest reliability, reproducibility, sensitivity 
to changes in psychotic symptoms, internal consistency, concurrent validity (compared to a 
valid psychotic symptom scale), and factor structure. The Chinese version demonstrated very 
satisfactory content validity as rated by an expert panel, good semantic equivalence with the 
original version, and high interrater and test–retest (at 2-week interval) reliability. It also indi-
cated very good reproducibility of and sensitivity to changes in psychotic symptoms in line with 
the symptom severity measured with the Positive and Negative Syndrome Scale (PANSS). The 
scale consisted of four factors for the hallucination subscale and two factors for the delusion 
subscale, explaining about 80% of the total variance of the construct, indicating satisfactory 
correlations between the hallucination and delusion factors themselves, between items, factors, 
subscales, and overall scale, and between factors and relevant item and subscale scores of the 
PANSS. The Chinese version of the PSYRATS is a reliable and valid instrument to measure 
symptom severity in Chinese psychotic patients complementary to other existing measures 
mainly in English language.
Keywords: delusion, hallucination, psychosis, PSYRATS, reliability, validity
Introduction
Schizophrenia and other psychotic disorders are chronic remitting and disruptive 
mental illnesses. In developed countries, psychotic patients constitute 40%–70% of 
the total patient population served by community mental health services.1 Psychotic 
symptoms, particularly auditory hallucination and delusions, are often disturbing, 
undesirable, and persistent; however, they are the key features or characteristics 
of psychoses. Difficulties in recovery from psychotic disorders have been closely 
associated with poor control and instability during these psychotic symptoms as well 
as nonadherence to medication and/or treatments.2,3 Very few structured assessment 
tools measure single or multiple domains/dimensions of psychotic symptoms, for 
example, Oulis Auditory Hallucinations Rating Scale4 and Delusions Inventory5 for 
single symptoms, or Positive and Negative Syndrome Scale (PANSS)6 and Revised 
Behavior and Symptom Identification Scale7 for overall symptoms. Among those 
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measures of psychotic symptoms, the Psychotic Symptom 
Rating Scales (PSYRATS)8 (Figure S1) consists of the 
multidimensional features of two main psychotic symptoms 
(ie, auditory hallucinations and delusions) in one measure-
ment tool, and the PSYRATS has been translated into differ-
ent languages, validated, and increasingly used for outcome 
evaluation of interventions for patients with acute and chronic 
psychotic disorders.9,10
The PSYRATS is an instrument conducted with semi-
structured interviews to measure the subjective character-
istics of auditory hallucinations and delusions in multiple 
dimensions, including their nature, persistence, amount, 
severity, and beliefs toward the symptoms.8 It has often 
been used in mental health research and practice settings 
focusing on the two cardinal symptoms of schizophrenia and 
psychotic disorders on top of the overall assessment of psy-
chotic symptoms (such as using the PANSyndrome Scale). 
This scale can assess more comprehensively the nature and 
severity of auditory hallucinations and delusions and thus 
provide more precise and accurate measurements on these 
two psychotic symptoms than other instruments for assess-
ing specific aspects of voices (eg, the Revised Beliefs About 
Voices Questionnaire11 and the Voices Acceptance and 
Action Scale12) and specific types of delusions (eg, Paranoid 
Thought Scales13 and Paranoia Scale14).
As recommended by the original authors,8 the PSYRATS 
consists of 17 items assessing two subscales (auditory 
hallucinations and delusions), with each item being rated 
on a 5-point scale (0= Absent to 4= Severe/Often/Extreme). 
The scale has demonstrated satisfactory internal consistency 
(Cronbach’s α=0.70–0.75),15 interrater reliabilities (interclass 
correlation coefficient (ICC) =0.79–0.90 and 0.90–1.00, 
respectively),8,16 test–retest reliabilities (ICC =0.50–0.74 
at 7-day interval),16 and item-to-subscale and item-to-item 
correlations (Pearson’s r=0.37–0.77, P=0.01–0.001 and 
r=0.49–0.54, P=0.001, respectively)8,15,16 in people with 
psychotic disorders in a few English speaking countries. The 
auditory hallucinations subscale (AHS) contains 11 items: 
frequency, duration, loudness, origin, amount and intensity 
of distress and negative contents, beliefs about the origin of 
voices, disruption to life, and controllability. The delusions 
subscale (DS) consists of six items: amount and duration of 
preoccupation; conviction, amount, and intensity of distress; 
and disruption to life. Several studies on its construct validity 
using exploratory factor analysis identified 3–4-factor solu-
tions within the two subscales.15–17 The original authors8 and 
Drake et al16 suggested the PSYRATS contained five dimen-
sions using the multidimensional scaling method (Euclidean 
matrices, alternating least-squares algorithm [ALSCAL] 
subroutine), in which the AHS distress and negative content 
items loaded onto one factor; frequency and duration loaded 
onto another one; and belief about voices, location, control, 
and disruption loaded onto the third dimension. However, 
the DS frequency, duration, conviction, and disruption items 
loaded onto one factor, and the amount and intensity of distress 
loaded onto another factor. But, Kronmȕller et al15 and Steel 
et al18 reported one additional dimension within the AHS items 
(controllability), thus including the four AHS dimensions (ie, 
emotional characteristics, physical characteristics, controlla-
bility, and cognitive interpretation). Validation studies on other 
language versions of the PSYRATS (eg, French, Indonesian, 
and German) supported the similar factor structure of the DS 
to the original study but could not find a clear-cut fourth factor 
structure (ie, controllability) for the AHS.15,19,20 With these dif-
ferences on factor structure across countries, further construct 
validity testing on the PSYRATS is suggested.
There is a paucity of validation of the PSYRATS in 
recent-onset psychosis, except one conducted by Drake 
et al,16 and there is also a paucity in studies in Chinese patient 
populations. Variability in the course of schizophrenia among 
patients from different cultures has been observed.21–23 With 
inconsistencies on factor structure between countries and 
limited symptom measures in Chinese populations, a reliabil-
ity and validity testing of a Chinese version of the PSYRATS 
is recommended to have better understanding of Chinese 
patients’ needs for treatments or interventions. Therefore, 
this study was done to examine the psychometric properties 
of a Chinese version of the PSYRATS (C-PSYRATS) in 
recent-onset and chronic psychosis.
Methods
sample and study settings
Patients with recent-onset (#3 year of the illness) and chronic 
($5 years) psychosis were recruited from the outpatient and 
day-patient facilities in two regional mental hospitals (Kwai 
Chung and Kowloon hospitals) of the New Territories and 
Kowloon, which serve 1.5 million people (20%) and take care 
of 40% of the psychotic patients in Hong Kong. These patients 
were recruited as part of three controlled trials to assess the 
effectiveness of mindfulness-based intervention, family 
self-help program, and adherence therapy in recent-onset 
psychosis and schizophrenia spectrum disorders.1,24,25 Ethical 
approvals to conduct the study were obtained from the 
Human Subjects Research Ethics Committee of The Hong 
Kong Polytechnic University (HSEARS2014121103) and 
Clinical Research Ethics Committee of the two hospital 
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clusters of Hospital Authority Hong Kong (ie, the Kowloon 
Central and West clusters). Written informed consent was 
obtained from individual patients for participation after full 
explanation of the study purpose and procedure.
Inclusion criteria of the participants were: Hong Kong 
Chinese residents, aged 18–65 years, and diagnosed with 
schizophrenia and its subtypes and other psychotic disor-
ders (onset #3 years or $5 years) according to the criteria 
of DSM-IV.26 Exclusion criteria were: comorbidities of 
organic brain disorder and learning disability, psychosis due 
to substance abuse, language and communication difficul-
ties, or having been judged by psychiatrist as mentally unfit 
to participate. At least 170 patients with recent-onset and 
chronic psychosis were recruited in order to ensure adequate 
sample size for exploratory and confirmatory factor analysis 
($10 subjects per item).27 Two subgroups of these partici-
pants (both n=50) was selected; one subgroup was randomly 
selected (from the patient list in alphabetical order of their 
surnames using computer-generated random numbers) to 
assess test–retest reliability of the C-PSYRATS and another 
subgroup was purposively selected (ie, .4 scores in hal-
lucination and delusion items of the PANSS) to assess its 
interrater reliability.
Procedure
Translation and back-translation
Translation of the English version of the PSYRATS into 
Chinese language followed the procedure of Brislin’s model28 
in order to develop a culturally equivalent instrument. The 
original English version was translated into Chinese language 
by two bilingual mental health nurses independently and then 
back-translated into English by a second bilingual translator. 
The meaning of the original scale items was compared with 
the back-translated version among the translators and two 
researchers.
content validity and semantic equivalence
Following the back-translation process, the bilingual version 
of the PSYRATS was administered to a panel of 10 persons 
who were experts in the study topic, including three psychia-
trists, two advanced practice psychiatric nurses, two clinical 
psychologists, and three bilingual speaking ex-patients 
to determine the content validity (using Content Validity 
Index) and semantic equivalence (using intracorrelation 
test) of the Chinese version of the C-PSYRATS. The panel 
rated the semantic equivalence of the C-PSYRATS items 
to the meaning of the items in the original English version 
using a 4-point Likert scale, including 1 (not appropriate), 
2 (somewhat appropriate), 3 (appropriate), and 4 (very 
appropriate). The panel was also invited to comment on 
the clarity and comprehensibility of the items and overall 
presentation and instructions of the instrument. The mem-
bers of the panel were also asked to independently rate the 
relevance of the content of the C-PSYRATS items and the 
overall scale to local clinical context on a 4-point Likert 
scale: 1 (not relevant), 2 (somewhat relevant), 3 (relevant), 
and 4 (very relevant). As suggested by Polit and Beck,29 
content validity index (CVI) of each item was determined 
by the proportion of experts who rated it as content valid 
(ie, rating of 3 or 4), and the CVI of the overall scale was 
determined by the proportion of all items ($80%) that were 
rated as content valid, for measuring the psychotic symptoms 
in local settings.
Validity testing
Patients were assessed within 5 days and reassessed 5 months 
later with the PANSS6 and C-PSYRATS by two psychia-
trists (trained to administer the two scales) for concurrent 
validity, construct validity (exploratory and confirmatory 
factor analysis using the data from recent-onset and chronic 
psychosis, respectively), reproducibility, and sensitivity to 
changes in psychotic symptoms. The widely used PANSS 
had the most similar construct of psychotic symptoms to the 
PSYRATS, thus being most appropriate to make comparisons 
between their scores for validity testing.
Reproducibility of the C-PSYRATS was assessed with 
random-effects one-way ANOVA test on the data from those 
who reported no major changes in positive symptoms (PANSS 
scores) between the two measurements (over 5 months), with 
ICC of $0.7 indicating satisfactory reproducibility.27 Respon-
siveness to change of the C-PSYRATS was assessed on the 
observed change in its two subscale scores over 5 months 
(ie, change divided by the baseline score minus the minimum 
possible score) to determine whether the mean change scores 
correlated with the PANSS hallucination/delusion item, 
positive symptom subscale, and/or total score.
Test–retest and interrater reliability
Sixty of the participants (30 from both recent-onset and 
chronic psychosis) were assessed with the C-PSYRATS at 
a 14-day interval to establish test–retest reliability, since 
these symptom scores were relatively stable over 1–2 weeks.8 
Another 60 participants who had scored 5 or more on the hal-
lucination and delusion items of the PANSS were purposively 
selected to assess interrater reliability of the C-PSYRATS 
rated by three trained psychiatrists.
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internal consistency
Internal consistency of the Chinese version and its subscales 
(refined after factor analysis) was tested by calculating the 
Cronbach’s α coefficients, which indicated the homogeneity 
of construct of the C-PSTRATS.
Results
study participants
One hundred ninety-eight patients with recent-onset psycho-
sis and 202 chronic psychotic patients were recruited, and 
120 (61%) and 108 (54%) were followed-up at 5 months, 
respectively (as part of the controlled trials by the research 
team).1,24,25 There were no significant differences on the 
demographic and clinical characteristics and symptom 
severity between the participants and nonparticipants at the 
two measurements (using χ2 or unpaired t-test; P.0.15). 
Overall, more than half of the 400 patients were male 
(n=220, 55%), and their mean age was 27.8 years (standard 
deviation =10.7). Majority of them were ethnic Chinese, 
either born in Hong Kong (n=321, 80%) or from mainland 
China (n=58, 15%), and were educated to a secondary school 
level or above (n=322, 81%). More than two-thirds (n=258, 
65%) were living with family members, and one-third had 
comorbidity with other mental illness such as mood disorders 
(n=39, 10%), anxiety disorders (n=28, 7%), and substance 
abuse (n=31, 8%).
Face validity, semantic equivalence, 
and content validity
The research team discussed about the discrepancies on the 
definitions of any items between the translated Chinese, 
back-translated English and original English versions of the 
PSYRATS and then clarified these with the translators. We 
had modified the wordings of only a few descriptions of the 
rating scales to ensure the congruence of meaning between the 
Chinese and English version, including “swear words” and “the 
milkman’s ugly” in item 7, AHS (Degree of negative content), 
“supported accommodation” in item 10, AHS (Disruption to life 
by voices) and item 6, DS (Disruption to life by beliefs), and 
“dismiss or bring on them” in item 11, AHS (Controllability). 
Otherwise, there were no amendments to the items and headings. 
The translated Chinese version is presented in Figure S2.
The intraclass correlation coefficients between the 
Chinese and the original English version were 0.92 (P=0.005) 
for the overall scale and from 0.88 to 0.98 for the two sub-
scales. Very minor amendments to the wordings of a few 
items were made (eg, “majority” and “minority” of voices, 
“conviction” to voices and “preoccupation” with delusions). 
The C-PSYRATS also showed very satisfactory content 
validity, with the item-level CVIs between 0.92 and 1.00 and 
scale-level CVI of 0.98.
interrater reliability
ICCs between three raters for subscale and total scores 
of the C-PSYRATS in recent-onset psychosis were very 
satisfactory, with a value of 0.92 for AHS, 0.95 for DS, 
and 0.94 for the overall scale. The ICCs between raters ranged 
0.82–1.00 for AHS items and 0.80–1.00 for DS items, except 
0.50 for “location of voices”. The ICCs between raters in 
chronic psychosis were also very satisfactory, with values 
of 0.80–1.00 for AHS and overall scale and 0.78–0.96 for 
DS, except that it was 0.42 for “location of voices”. There 
were small discrepancies (2%–6%) between raters on the 
C-PSYRATS subscale/total scores in recent-onset and 
chronic psychosis.
Test–retest reliability
Data from the 60 participants after a 14-day interval were 
compared, and the ICCs were 0.81 and 0.82 for AHS and 
0.85 and 0.81 for DS in recent-onset and chronic psychosis, 
respectively. The ICCs for individual AHS and DS items 
in recent-onset psychosis were 0.76–0.88 and 0.80–0.90, 
respectively, whereas the ICCs for AHS and DS items were 
0.72–0.82 and 0.76–0.85, respectively, in chronic psychosis. 
Over the 14 days of measurement, there were very minimal 
changes detected in levels of positive symptoms (ie, 0.2–0.9 
or 0.4%–2.5% of changes in positive symptom subscale of 
the PANSS) among both illness groups.
concurrent validity
In recent-onset psychosis, both the AHS and DS significantly 
correlated with the PANSS hallucination/delusion item 
(Pearson’s r=0.56 and 0.68 and P=0.007 and 0.002, respec-
tively), positive symptom subscale (r=0.32 and 0.38 and 
P=0.03 and 0.02, respectively), and total score (r=0.26 and 
0.29 and P=0.05 and 0.04, respectively). Similarly, both the 
AHS and DS in chronic psychosis significantly correlated 
with the PANSS hallucination/delusion item (r=0.54 and 0.62 
and P=0.008 and 0.005), positive symptom subscale (r=0.35 
and 0.38 and P=0.02 and 0.01), and total score (r=0.29 and 
0.32 and P=0.04 and 0.03).
reproducibility and sensitivity to changes 
in symptom severity
Reproducibility of the C-PSYRATS between the 5-month 
measurements was found to have ICCs of 0.86 (F=7.25, 
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P=0.003) in recent-onset psychosis and 0.78 (F=5.60, 
P=0.01) for chronic psychosis, indicating a very satisfactory 
consistency in testing the psychotic symptoms of those 
mentally stable patients in the two illness groups using 
the C-PSYRATS.
The observed changes in the AHS, DS, and total score 
of the C-PSYRATS were 1.1, 1.2, and 2.0 in recent-onset 
psychosis and 1.2, 1.3, and 2.2 in chronic psychosis, accord-
ingly. Change in the AHS significantly correlated with the 
changes in the PANSS hallucination item (Spearman’s 
r=0.70 and 0.63, P=0.005 and 0.009), positive symptom 
subscale (r=0.60 and 0.52, P=0.01 and 0.03), and total score 
(r=0.66 and 0.53, P=0.007 and 0.02) in both illness groups. 
Similarly, change in the DS significantly correlated with that 
in the PANSS delusion item (r=0.81 and 0.79, P=0.001 and 
0.002), positive symptom subscale (r=0.64 and 0.56, P=0.008 
and 0.02), and total score (r=0.68 and 0.57, P=0.005 and 
0.02) in both illness groups.
construct validity
Principal components analysis followed by oblique rotation 
was performed for the data from 198 patients with recent-onset 
psychosis, using SPSS for Windows version 20.0 (SPSS Inc., 
Chicago, IL, USA). The data indicated satisfactory item-total 
correlations (.0.30), adequate sample size, and factorabil-
ity (ie, Kaiser-Meyer-Oklin value of 0.84 and Bartlett test 
of Sphericity χ2=1,304.3, df=194, P,0.001) for factor 
analysis.27 Considering the Catell’s scree plot (Figure 1), 
six principal factors were initially extracted with .1.0 
in the unrotated matrix. All 17 items met the criterion on 
factor loading of .0.40, and were thus retained for oblique 
rotation.30 The rotated solution revealed that each of the 
six factors contained of a few items, which were loaded 
substantially (.0.65) on one factor only. The results of the 
oblique rotation are presented in Table 1. The six factor 
solutions included: four for the AHS, 1) amount and degree 
of negative content and distress, 2) frequency and duration, 
3) loudness, disruption, and controllability, and 4) location 
and beliefs regarding origin; and two for the DS, 5) amount 
and duration of preoccupation and conviction, and 6) amount 
and intensity of distress and disruption to life (by beliefs). 
These six factors explained 80.1% of the total variance of the 
symptom construct in recent-onset psychosis. The six factors 
also moderately to highly correlated with the C-PSYRATS 
total score (Pearson’s r=0.48–0.80, P=0.01–0.001) and were 
moderately intercorrelated (r=0.33–0.76, P=0.05–0.005).
Confirmatory factor analysis (using the LISREL 9.1 
software, Scientific Software International, Skokie, IL, USA) 
on the data collected from the 202 participants with chronic 
psychosis was then performed to compare between the six 
factors identified from the exploratory factor analysis and 
those (five-factor model) suggested by the original authors,8 
in order to determine the maximum likelihood “goodness-of-
fit” of these predetermined factor models. A summary of the 
Fit indices of the two models of the C-PSYRATS with both 
uncorrelated and correlated factors is shown in Table 2.
The first model (Table 2) identified from those with 
recent-onset psychosis appears to fit the data very well. 
The six-factor model with paths between all factors showed 
very good fit according to all fit indices (χ2/df=2.14, P=0.54; 
adjusted goodness of fit [AGFI] =0.97; Tucker-Lewis 
index [TLI] =1.04; root mean square error of approxi-
mation [RMSEA] =0.034; weighted root mean residual 
[WRMR] =0.79), indicating that it was better than the 
original five-factor model. Critical ratios for the regression 
weights were all .2.5 (ie, each item had a significant con-
tribution to its correlated factor). Indeed, the original five-
factor model indicated an acceptable fit (χ2/df=1.96, P=0.32; 
AGFI =0.90; TLI =0.96; RMSEA =0.049; WRMR =0.88). 
In addition, model modification indices for the six-factor 
model indicated good fits, particularly when additional 
paths were drawn between factors. The path diagram 
showed that there were moderate to moderate-high correla-
tions between factors and corresponding items (Pearson’s 
r=0.48–0.75, P=0.02–0.003) and between the factors them-
selves (r=0.38–0.82, P=0.01–0.001).
internal consistency
Cronbach’s α coefficients of the Chinese version (after factor 
analysis) were 0.89 for the overall scale and 0.86 and 0.90 
for the AHS and DS, respectively, indicating very good Figure 1 catell’s scree plot in exploratory factor analysis.
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homogeneity of the construct(s) of the C-PSYRATS in 
recent-onset psychosis. The α coefficients of the C-PSYRATS 
in chronic psychosis were 0.87, 0.84, and 0.89 for the overall 
scale, AHS, and DS, accordingly.
Discussion
This study examined the psychometric properties of a Chinese 
version of the PSYRATS (C-PSYRATS) in both recent-onset 
and chronic psychosis. The time for completion of the scale 
was acceptable, lasting about 10 minutes. The C-PSYRATS 
demonstrated very similar conceptual meanings of the 
items to the original version and was relevant and appropri-
ate to assess the psychotic symptoms as indicated by very 
good results of content validity and semantic equivalence. 
The overall scale and its two subscales (AHS and DS) showed 
high Cronbach’s α values, indicating very satisfactory inter-
nal consistency or homogeneity of the construct of the Chi-
nese version. The high intraclass correlations of the repeated 
and between-assessor ratings of the 60 psychotic patients 
indicated a high stability of the C-PSYRATS over a reason-
able 2-week interval and between trained raters. The ratings 
on the item for the location of voices much varied between 
the assessors and this might be due to the differences on the 
patients’ personal attributions of meaning to their experiences 
of the voices; and thus they hesitated to inform whether the 
voices generated from inside or outside the head or self, as 
suggested by the Hearing Voices Movement.31 Such patients’ 
challenge and difficulty in appraising their relationship with 
Table 1 results of oblique rotation of four factor solutions for c-PsYraTs in recent psychosis (N=198)
Items Factor loading
Factor 1 Factor 2 Factor 3 Factor 4 Factor 5 Factor 6
 1. ah – Frequency 0.88
 2. ah – Duration 0.87
 3. ah – location 0.73
 4. ah – loudness 0.70
 5. ah – Beliefs regarding origin of voices 0.80
 6. ah – amount of negative content 0.68
 7. ah – Degree of negative content 0.72
 8. ah – amount of distress 0.80
 9. ah – intensity of distress 0.82
 10. ah – Disruption to life caused by voices 0.80
 11. ah – controllability 0.88
 12. D – amount of preoccupation 0.88
 13. D – Duration of preoccupation 0.89
 14. D – conviction 0.84
 15. D – amount of distress 0.80
 16. D – intensity of distress 0.90
 17. D – Disruption to life 0.89
eigen value 7.75 2.31 3.59 1.48 4.90 5.21
Percentage of variance explained 18.02 9.40 13.76 9.51 14.55 14.82
Notes: Factor loadings $0.40 are reported. For ah, Factor 1= emotional; Factor 2= Physical; Factor 3= control; Factor 4= cognitive. For D, Factor 5= cognitive; 
Factor 6= emotional.
Abbreviations: c-PsYraTs, chinese version of Psychotic symptom rating scales; ah, auditory hallucination subscale; D, delusion subscale.
Table 2 Summary of fit indices of two hypothesized models of C-PSYRATS (N=202)
Model χ2 df χ2/df P-value GFI AGFI TLI RMSEA (90% CI) SRMR WRMR
six-factor model
Uncorrelated factors 68.98 30 2.30 0.56 1.00 0.95 1.00 0.036 (0.028–0.042) 0.022 0.82
correlated factorsa 62.10 29 2.14 0.54 0.99 0.97 1.04 0.034 (0.027–0.040) 0.019 0.79
Five-factor model
Uncorrelated factors 70.65 37 1.91 0.30 0.90 0.89 0.91 0.047 (0.040–0.054) 0.046 0.89
correlated factors 68.63 35 1.96 0.32 0.91 0.90 0.96 0.049 (0.038–0.058) 0.048 0.88
Notes: Six-factor model identified in this research in recent-onset psychosis; Five-factor model suggested by the original authors (Haddock et al8). aModel fit indices tested 
with paths (correlations) set up between the hypothesized factors in each model. χ2= Chi-squared goodness-of-fit; df= degree of freedom; P-value (a good fit if P$0.1).
Abbreviations: GFI, goodness-of-fit index (range 0–1, a good-fit if GFI $0.9); AGFI, adjusted good-of-fit index (similar to GFI, a good-fit if AGFI $0.9); Tli, Tucker-lewis 
index (0.90–0.95 acceptable, a good-fit if TLI .0.95); RMSEA, root mean square error of approximation (a good-fit if RMSEA #0.05); SRMR, standardized root mean square 
residual (a good-fit if SRMR ,0.05); WRMR, weighted root mean residual (a good-fit if WRMR ,0.90).
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the voices should be further explored in order to better under-
stand patients’ personal meaning assigned to the voices, thus 
leading to better coping with this symptom.
Moreover, the C-PSYRATS demonstrated significant 
association (high concurrent validity) with the widely used 
psychotic symptom scale (PANSS) regarding hallucina-
tions and delusions. The overall and subscale scores of the 
C-PSYRATS indicated very satisfactory reproducibility and 
sensitivity to change in psychotic symptoms (PANSS total and 
subscale scores) in both recent-onset and chronic psychosis 
over 5 months. These results support the C-PSYRATS to be a 
valid instrument or outcome measure to measure the symptom 
severity among these psychotic patients across time, as well 
as in terms of various dimensions (eg, amount, duration and 
level of disruption) of hallucinations and delusions.
The exploratory factor analysis demonstrated a six-factor 
structure of the C-PSYRATS, which is similar to the ones 
suggested by Kronmȕller et al15 and Steel et al,18 and more 
importantly, these factors explained very high percentage 
(.80%) of the total variance of the symptom construct in 
recent-onset psychosis. For auditory hallucination subscale 
(AHS), two items (disruption to life and control) from cog-
nitive interpretation and one item (loudness) from physical 
characteristics suggested by the original authors were loaded 
onto one additional factor termed “controllability”. Such 
inconsistencies in factor structure of the AHS reveal the 
lack of clear understanding about the complex nature and 
heterogeneity of hallucinatory experiences or dimensions.20 
As suggested by Steel et al,18 the negative impacts (disrup-
tions) of voices on patients’ life are strongly connected with 
the loudness of and control over their voices experienced, 
which sometimes improves earlier than other dimensions of 
the hallucinations.32 With respect to the delusion subscale 
(DS), the two dimensions identified are consistent with the 
findings of most previous studies,18 even though disruption 
to life was loaded onto amount, duration, and conviction of 
delusions in two previous studies.8,15,16
The six-factor model of the C-PSYRATS identified from 
recent-onset psychosis was found the best fit in the confirma-
tory factor analysis for chronic psychosis. Therefore, the six 
dimensions of psychotic symptoms (AHS and DS) can better 
explain the symptom construct in two different psychotic 
patient populations than the original five-factor model pro-
posed by Haddock et al.8 It is important and useful to confirm 
these dimensions of AHS and DS in the C-PSYRATS because 
these item clusters may reflect the underlying etiological pro-
cess of psychosis.17 For instance, the amount and duration 
of preoccupation and conviction items (plus the disruption 
item) have clustered into one dimension (factor) of the DS. 
This may reflect that delusion might be affected by cognitive 
bias in which the false beliefs persist against evidence of dis-
confirmation or easily tend to jump into a subjective biased 
conclusion.33 The amount and degree of negative content 
and distress could co-occur and be interconnected and thus 
represent the emotional reactions toward the voices. This can 
help distinguish clinically diagnosed psychotic patients from 
nonclinically diagnosed voice-hearing persons.34
There were a few main limitations of this study. The study 
sample were those participated in one of the three controlled 
trials conducted by the first author. These samples, recruited 
from two of 14 psychiatric outpatient and day care facilities, 
might not be representative to the psychotic patient popula-
tion in Hong Kong. Those with acute psychotic symptoms 
and/or lack of insight into the illness could not have been 
included into this study. In addition, the sample was selec-
tive because most of the participants were well educated 
and relatively mentally stable Hong Kong-born Chinese 
people. Therefore, these results are in need of replication 
in psychotic patients at psychiatric hospital and rehabilita-
tion settings and in those in different stages of psychosis. 
It is also noteworthy that the PSYRATS was developed to 
mainly measure auditory hallucinations and all delusions 
in general, which cannot fully represent the variety of psy-
chotic symptoms or symptom severity. As suggested by a 
critical review on treatment targets in schizophrenia,35 it is 
of high relevance to capture other important domains than 
these two cardinal symptoms, such as negative and cognitive 
symptoms and even subjective experiences of the illness, as 
what constitutes an acceptable clinical status is hard to define 
and reasonably target to evaluate for an effective treatment 
regimen in clinical settings. It is also unknown whether the 
identified dimensions of the C-PSYRATS can represent 
exhaustively all important dimensions of hallucinations and 
delusions, particularly due to the fact that development of the 
scale was based on interviews with patients with persistent 
auditory hallucination.8 A future study can investigate how 
the overall scale, two subscales, and identified dimensions 
of the C-PSYRATS are associated with demographic and 
illness-related correlates and specific responses to psychotic 
symptoms such as mindfulness, acceptance, or omnipotence 
of beliefs about hallucinations.
Conclusion
The C-PSYRATS has demonstrated very good reliability 
and validity in both recent-onset and chronic psychosis. 
It also indicated a high concurrent validity with the widely 
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accepted psychotic symptom measure (PANSS). This scale 
has the advantage of easy administration with minimal 
training and provides detailed assessment of different 
dimensions of auditory hallucinations and delusions. The 
six dimensions of the scale identified can lead to better 
understanding of the underlying etiological processes of 
these psychotic symptoms and allow precise measurement 
of the changes in the corresponding symptom dimension(s). 
Further research is recommended to test the psychometric 
properties of the C-PSYRATS, particularly its predictive, 
discriminatory, and construct validity, in larger samples of 
Chinese patients with diverse sociodemographic, illness, and 
other clinical characteristics.
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